Cleared Traditional

MOZI TPS (K223724) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K223724 · Manteia Technologies Co., Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2023
Decision
209d
Days
Class 2
Risk

K223724 is an FDA 510(k) clearance for the MOZI TPS. Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by Manteia Technologies Co., Ltd. (Xiamen, CN). The FDA issued a Cleared decision on July 10, 2023 after a review of 209 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Manteia Technologies Co., Ltd. devices

Submission Details

510(k) Number K223724 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 13, 2022
Decision Date July 10, 2023
Days to Decision 209 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
102d slower than avg
Panel avg: 107d · This submission: 209d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 112
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K223724.
ART-Plan
K232479 · Therapanacea · Dec 2023
Panther TPS
K231825 · Prowess, Inc. · Dec 2023
VariSeed (v10)
K232400 · Varian Medical Systems · Sep 2023
Eclipse Treatment Planning System (v18.0)
K230557 · Varian Medical Systems, Inc. · May 2023
Radiation Planning Assistant (RPA)
K222728 · University of Texas, MD Anderson Cancer Center · May 2023
RayStation 12A
K222312 · RaySearch Laboratories AB (PUBL) · Mar 2023